Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

JAMP Temozolomide

Canada Type II Ongoing · initiated 2026-08-31

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Apo-Semaglutide

Canada Type II Ongoing · initiated 2026-08-27

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Semaglutide Injection

Canada Type II Ongoing · initiated 2026-08-26

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Twins Herbal Idakole and Twins Herbal Pelorie

Canada Type I Ongoing · initiated 2026-08-25

Undeclared substance. Discontinue use of the affected products. Consult your healthcare provider for any health concerns.Do not buy or use unauthorized health p…

Hikma Pharmaceuticals USA INC.

US Class II Ongoing · initiated 2026-08-24

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

Canada Type III Ongoing · initiated 2026-08-19

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Lactated Ringer's Injection USP

Canada Type I Ongoing · initiated 2026-08-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Safecor Health, LLC

US Not Yet Classified Ongoing · initiated 2026-08-14

Cross Contamination with Other Products

Apotex Corp.

US Class II Ongoing · initiated 2026-08-13

Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

Adequan I.M

Canada Type III Ongoing · initiated 2026-08-12

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

pms-IRBESARTAN 150 mg Tablet

Canada Type II Ongoing · initiated 2026-08-12

Contamination. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any h…

B BRAUN MEDICAL INC

US Class I Ongoing · initiated 2026-08-12

Presence of Particulate matter.

Semaglutide Injection

Canada Type II Ongoing · initiated 2026-08-11

Packaging. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.Co…

Church & Dwight Co., Inc.

US Class II Ongoing · initiated 2026-08-10

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

Fresenius Kabi USA, LLC

US Class I Ongoing · initiated 2026-08-10

Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

TEVA-ECTOSONE 0.1% Cream

Canada Type II Ongoing · initiated 2026-08-07

Labelling. Verify if your product is affected. If the lot number and expiry date are missing, your product may be affected by this recall.Consult your healthcar…

Golden State Medical Supply Inc.

US Class II Ongoing · initiated 2026-08-07

CGMP deviations: tablets with black specks.

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

Mallinckrodt Hospital Products Inc.

US Class II Ongoing · initiated 2026-08-06

Presence of particulate matter: glass and stopper piece